| Record ID | marc_loc_2016/BooksAll.2016.part19.utf8:95342242:1057 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part19.utf8:95342242:1057?format=raw |
LEADER: 01057pam a2200289 a 4500
001 89011413
003 DLC
005 19891114164034.9
008 890519s1989 gw a b 00100 eng c
010 $a 89011413
020 $a0387821333 (U.S.)
040 $aDNLM/DLC$cDLC
050 0 $aRC535$b.R48 1989
060 $aW1 JO781A no. 28$aWM 171 R452
082 0 $a616.85/27061$220
245 00 $aReversible MAO-A inhibitors as antidepressants :$bbasic advances and clinical perspectives /$cG.D. Burrows and M. Da Prada (eds.).
260 0 $aWien ;$aNew York :$bSpringer-Verlag,$cc1989.
300 $a106 p. :$bill. ;$c28 cm.
440 0 $aJournal of neural transmission.$pSupplementum,$x0303-6995 ;$v28
504 $aIncludes bibliographical references.
650 0 $aDepression, Mental$xChemotherapy.
650 0 $aMoclobemide.
650 0 $aMonoamine oxidase$xInhibitors$xTherapeutic use.
650 2 $aDepressive Disorder$xdrug therapy.
650 2 $aMonoamine Oxidase Inhibitors$xtherapeutic use.
700 10 $aBurrows, Graham D.
700 10 $aDa Prada, M.